Recent Articles
- Pattern Bioscience Appoints David Barreca as Vice President of Sales
- Pattern Bioscience Surpasses 1,000 Samples in Multi-Center Clinical Trial of Rapid Pneumonia Diagnostic
- Pattern Bioscience Raises $43 Million in Series D Financing to Pursue FDA Clearance for Its Rapid Pneumonia Diagnostic
- Pattern Bioscience Names Carey-Ann Burnham CEO
- Pattern Awarded $22.5M BARDA Contract to Advance Single-Cell Microbiology System and Critical Care Antimicrobial Susceptibility Testing Panels for Pneumonia and Bacteremia